Muhammad Omair Sultan Meo, Noara AlHusseini, Dania Imad Ibrahim, Muhammad Zain Sultan Meo, Faridul Ahsan, Hani Tamim, Muhammad Raihan Sajid
{"title":"Clinical manifestations of Long-COVID: an observational perspective.","authors":"Muhammad Omair Sultan Meo, Noara AlHusseini, Dania Imad Ibrahim, Muhammad Zain Sultan Meo, Faridul Ahsan, Hani Tamim, Muhammad Raihan Sajid","doi":"10.3389/fmed.2025.1523817","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Coronavirus Disease-19, also known as COVID-19, resulted in a pandemic that caused massive health concerns and economic losses globally. Worldwide, people are still facing persistent clinical symptoms following COVID-19 infection, characterized as Long-COVID. This study aimed to assess the experience and awareness of Long-COVID clinical symptoms in Saudi Arabia.</p><p><strong>Methods: </strong>This cross-sectional study was conducted at the College of Medicine, Alfaisal University, Riyadh, Saudi Arabia during the period April 5, 2023 to August 30, 2023. An online questionnaire was created using Google Forms and distributed with a URL to students via email and WhatsApp. The questionnaire consisted of 17 questions classifying the respondent's responses. The survey consisted of three sections, addressing demographics, their experience with COVID-19 and whether they had Long-COVID symptoms. A total of 490 participants participated in the study survey. The Statistical Package for Social Sciences (SPSS) version 28 was used for data administration and analysis. <i>P</i>-values <0.05 were considered statistically significant.</p><p><strong>Results: </strong>Out of the participants, 53.9% had prior exposure to COVID-19. During acute infection, tiredness was the most common symptom in participants, observed in 84.5% of people. The other common symptoms which were reported among the participants included fever (75%), soreness of throat (65.5%), headache (65.2). Some symptoms were more dominant in males (such as acne) and some in females (hair loss). Regarding prolonged symptoms, 43.6% of females and 33.3% of males had experienced symptoms of Long-COVID. Tiredness was once again the most dominant symptom (16.7%). The other common prolonged symptoms of Long-COVID observed were loss of taste or smell (9.1%), body pain (7.6%), headache (7.2%), foggy memory (7.2%) and shortness of breath (6.4%). Lastly, awareness of Long COVID was lower than expected, with 51.5% of females and 55.1% of males unaware of the syndrome.</p><p><strong>Conclusion: </strong>This study's findings show the effects Long COVID-19 has on the general population, which includes various symptoms affecting physical, mental and emotional needs. The findings also suggest potential gender differences in Long-COVID clinical symptoms, thus highlighting the need for further research with larger and more diverse samples.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1523817"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11961443/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1523817","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Coronavirus Disease-19, also known as COVID-19, resulted in a pandemic that caused massive health concerns and economic losses globally. Worldwide, people are still facing persistent clinical symptoms following COVID-19 infection, characterized as Long-COVID. This study aimed to assess the experience and awareness of Long-COVID clinical symptoms in Saudi Arabia.
Methods: This cross-sectional study was conducted at the College of Medicine, Alfaisal University, Riyadh, Saudi Arabia during the period April 5, 2023 to August 30, 2023. An online questionnaire was created using Google Forms and distributed with a URL to students via email and WhatsApp. The questionnaire consisted of 17 questions classifying the respondent's responses. The survey consisted of three sections, addressing demographics, their experience with COVID-19 and whether they had Long-COVID symptoms. A total of 490 participants participated in the study survey. The Statistical Package for Social Sciences (SPSS) version 28 was used for data administration and analysis. P-values <0.05 were considered statistically significant.
Results: Out of the participants, 53.9% had prior exposure to COVID-19. During acute infection, tiredness was the most common symptom in participants, observed in 84.5% of people. The other common symptoms which were reported among the participants included fever (75%), soreness of throat (65.5%), headache (65.2). Some symptoms were more dominant in males (such as acne) and some in females (hair loss). Regarding prolonged symptoms, 43.6% of females and 33.3% of males had experienced symptoms of Long-COVID. Tiredness was once again the most dominant symptom (16.7%). The other common prolonged symptoms of Long-COVID observed were loss of taste or smell (9.1%), body pain (7.6%), headache (7.2%), foggy memory (7.2%) and shortness of breath (6.4%). Lastly, awareness of Long COVID was lower than expected, with 51.5% of females and 55.1% of males unaware of the syndrome.
Conclusion: This study's findings show the effects Long COVID-19 has on the general population, which includes various symptoms affecting physical, mental and emotional needs. The findings also suggest potential gender differences in Long-COVID clinical symptoms, thus highlighting the need for further research with larger and more diverse samples.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world